|
Intellipharmaceutics Announces Second Quarter 2014 Results
Wall Street Journal The Company recorded a net loss for the three months ended May 31, 2014 of $3.1 million, or $0.14 per common share, compared with a net loss of $1.8 million, or $0.09 per common share for the three months ended May 31, 2013. ….. from convertible … |
